Progressive region-specific de novo methylation of the p16 CpG island in primary human mammary epithelial cell strains during escape from M0 growth arrest

Molecular and Cellular Biology

Volumn 19, Issue 8, 1999, Pages 5642-5651

  Wong, David J ^a   Foster, Scott A ^a   Galloway, Denise A ^a   Reid, Brian J ^a,b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOSINE; DNA;

ARTICLE; BREAST EPITHELIUM; CELL GROWTH; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; GENE EXPRESSION; GENE LOCUS; GENE SEQUENCE; GENE SILENCING; GENETIC TRANSCRIPTION; GROWTH INHIBITION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; TUMOR ESCAPE; TUMOR SUPPRESSOR GENE;

EID: 0032770313     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.19.8.5642     Document Type: Article

References (63)

1. Alcorta, D. A., Y. Xiong, D. Phelps, G. Hannon, D. Beach, and J. C. Barrett. 1996. Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts. Proc. Natl. Acad. Sci. USA 93:13742-13747.
2. An, H. X., D. Niederacher, F. Picard, C. van Roeyen, H. G. Bender, and M. W. Beckmann. 1996. Frequent allele loss on 9p21-22 defines a smallest common region in the vicinity of the CDKN2 gene in sporadic breast cancer. Genes Chromosomes Cancer 17:14-20.
3. Band, V., and R. Sager. 1989. Distinctive traits of normal and tumor-derived human mammary epithelial cells expressed in a medium that supports long-term growth of both cell types. Proc. Natl. Acad. Sci. USA 86:1249-1253.
4. Baylin, S. B., J. G. Herman, J. R. Graff, P. M. Vertino, and J. P. Issa. 1998. Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv. Cancer Res. 72:141-196.
5. Bestor, T. 1987. Supercoiling-dependent sequence specificity of mammalian DNA methyltransferase. Nucleic Acids Res. 15:3835-3843.
6. Bolden, A. H., C. M. Nalin, C. A. Ward, M. S. Poonian, and A. Weissbach. 1986. Primary DNA sequence determines sites of maintenance and de novo methylation by mammalian DNA methyltransferases. Mol. Cell. Biol. 6:1135-1140.
7. Boyes, J., and A. Bird. 1992. Repression of genes by DNA methylation depends on CpG density and promoter strength: evidence for involvement of a methyl-CpG binding protein. EMBO J. 11:327-333.
8. Brandeis, M., D. Frank, I. Keshet, Z. Siegfried, M. Mendelsohn, A. Nemes, V. Temper, A. Razin, and H. Cedar. 1994. Sp1 elements protect a CpG island from de novo methylation. Nature 371:435-438.
9. Brenner, A. J., M. R. Stampfer, and C. M. Aldaz, 1998. Increased p16 expression with first senescence arrest in human mammary epithelial cells and extended growth capacity with p16 inactivation. Oncogene 17:199-205.
10. Cairns, P., L. Mao, A. Merlo, D. J. Lee, D. Schwab, Y. Eby, K. Tokino, P. van der Riet, J. E. Blaugrund, and D. Sidransky. 1994. Rates of p16 (MTS1) mutations in primary tumors with 9p loss. Science 265:415-417. (Letter.)
11. Cairns, P., T. J. Polascik, Y. Eby, K. Tokino, J. Califano, A. Merlo, L. Mao, J. Herath, R. Jenkins, W. Westra, et al. 1995. Frequency of homozygous deletion at p16/CDKN2 in primary human tumours. Nat. Genet. 11:210-212.
12. Caldas, C., S. A. Hahn, L. T. da Costa, M. S. Redston, M. Schutte, A. B. Seymour, C. L. Weinstein, R. H. Hruban, C. J. Yeo, and S. E. Kern. 1994. Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma. Nat. Genet. 8:27-32. (Erratum, 8:410.)
13. Carotti, D., S. Funiciello, F. Palitti, and R. Strom. 1998. Influence of preexisting methylation on the de novo activity of eukaryotic DNA methyltransferase. Biochemistry 37:1101-1108.
14. Carotti, D., F. Palitti, P. Lavia, and R. Strom. 1989. In vitro methylation of CpG-rich islands. Nucleic Acids Res. 17:9219-9229.
15. Clark, S. J., J. Harrison, and M. Frommer. 1995. CpNpG methylation in mammalian cells. Nat. Genet. 10:20-27.
16. Erlich, H. A. 1992. PCR technology: principles and applications for DNA amplification. W. H. Freeman & Co., New York, N.Y.
17. Foster, S. A., and D. A. Galloway. 1996. Human papillomavirus type 16 E7 alleviates a proliferation block in early passage human mammary epithelial cells. Oncogene 12:1773-1779.
18. Foster, S. A., D. J. Wong, M. T. Barrett, and D. A. Galloway. 1998. Inactivation of p16 in human mammary epithelial cells by CpG island methylation. Mol. Cell. Biol. 18:1793-1801.
19. Frommer, M., L. E. McDonald, D. S. Millar, C. M. Collis, F. Watt, G. W. Grigg, P. L. Molloy, and C. L. Paul. 1992. A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc. Natl. Acad. Sci. USA 89:1827-1831.
20. Gonzalez-Zulueta, M., C. M. Bender, A. S. Yang, T. Nguyen, R. W. Beart, J. M. Van Tornout, and P. A. Jones. 1995. Methylation of the 5′ CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Cancer Res. 55:4531-4535.
21. Gonzalgo, M. L., T. Hayashida, C. M. Bender, M. M. Pao, Y. C. Tsai, F. A. Gonzales, H. D. Nguyen, T. T. Nguyen, and P. A. Jones. 1998. The role of DNA methylation in expression of the p19/p16 locus in human bladder cancer cell lines. Cancer Res. 58:1245-1252.
22. Gonzalgo, M. L., and P. A. Jones. 1997. Rapid quantitation of methylation differences at specific sites using methylation-sensitive single nucleotide primer extension (Ms-SNuPE). Nucleic Acids Res. 25:2529-2531.
23. Halbert, C. L., G. W. Demers, and D. A. Galloway. 1991. The E7 gene of human papillomavirus type 16 is sufficient for immortalization of human epithelial cells. J. Virol. 65:473-478.
24. Herman, J. G., J. R. Graff, S. Myohanen, B. D. Nelkin, and S. B. Baylin. 1996. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc. Natl. Acad. Sci. USA 93:9821-9826.
25. Herman, J. G., A. Merlo, L. Mao, R. G. Lapidus, J. P. Issa, N. E. Davidson, D. Sidransky, and S. B. Baylin. 1995. Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res. 55:4525-4530.
26. Hornstra, I. K., and T. P. Yang. 1994. High-resolution methylation analysis of the human hypoxanthine phosphoribosyltransferase gene 5′ region on the active and inactive X chromosomes: correlation with binding sites for transcription factors. Mol. Cell. Biol. 14:1419-1430.
27. Hsieh, C.-L. 1994. Dependence of transcriptional repression on CpG methylation density. Mol. Cell. Biol. 14:5487-5494.
28. Huschtscha, L. I., J. R. Noble, A. A. Neumann, E. L. Moy, P. Barry, J. R. Melki, S. J. Clark, and R. R. Reddel. 1998. Loss of p16INK4 expression by methylation is associated with lifespan extension of human mammary epithelial cells. Cancer Res. 58:3508-3512.
29. Iguchi-Ariga, S. M., and W. Schaffner. 1989. CpG methylation of the cAMP-responsive enhancer/promoter sequence TGACGTCA abolishes specific factor binding as well as transcriptional activation. Genes Dev. 3:612-619.
30. INK4a-mediated growth suppression. Mol. Cell. Biol. 18: 5284-5290.
31. Jones, P. A. 1996. DNA methylation errors and cancer. Cancer Res. 56:2463-2467.
32. Kass, S. U., J. P. Goddard, and R. L. P. Adams. 1993. Inactive chromatin spreads from a focus of methylation. Mol. Cell. Biol. 13:7372-7379.
33. Kiyono, T., S. A. Foster, J. I. Koop, J. K. McDougall, D. A. Galloway, and A. J. Klingelhutz. 1998. Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells. Nature 396:84-88.
34. Laborda, J. 1991. 36B4 cDNA used as an estradiol-independent mRNA control is the cDNA for human acidic ribosomal phosphoprotein PO. Nucleic Acids Res. 19:3998.
35. Loughran, O., A. Malliri, D. Owens, P. H. Gallimore, M. A. Stanley, B. Ozanne, M. C. Frame, and E. K. Parkinson. 1996. Association of CDKN2A/ p16INK4A with human head and neck keratinocyte replicative senescence: relationship of dysfunction to immortality and neoplasia. Oncogene 13:561-568.
36. Macleod, D., J. Charlton, J. Mullins, and A. P. Bird. 1994. Sp1 sites in the mouse aprt gene promoter are required to prevent methylation of the CpG island. Genes Dev. 8:2282-2292,
37. Merlo, A., J. G. Herman, L. Mao, D. J. Lee, E. Gabrielson, P. C. Burger, S. B. Baylin, and D. Sidransky. 1995. 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nat. Med. 1:686-692.
38. Noble, J. R., E. M. Rogan, A. A. Neumann, K. Maclean, T. M. Bryan, and R. R. Reddel. 1996. Association of extended in vitro proliferative potential with loss of p16INK4 expression. Oncogene 13:1259-1268.
39. Oberle, I., F. Rousseau, D. Heitz, C. Kretz, D. Devys, A. Hanauer, J. Boue, M. F. Bertheas, and J. L. Mandel. 1991. Instability of a 550-base pair DNA segment and abnormal methylation in fragile X syndrome. Science 252:1097-1102.
40. Park, J.-G., and V. M. Chapman. 1994. CpG island promoter region methylation patterns of the inactive-X-chromosome hypoxanthine phosphoribosyltransferase (Hprt) gene. Mol. Cell. Biol. 14:7975-7983.
41. Pfeifer, G. P., S. D. Steigerwald, R. S. Hansen, S. M. Gartler, and A. D. Riggs. 1990. Polymerase chain reaction-aided genomic sequencing of an X chromosome-linked CpG island: methylation patterns suggest clonal inheritance, CpG site autonomy, and an explanation of activity state stability. Proc. Natl. Acad. Sci. USA 87:8252-8256.
42. Pfeifer, G. P., R. L. Tanguay, S. D. Steigerwald, and A. D. Riggs. 1990. In vivo footprint and methylation analysis by PCR-aided genomic sequencing: comparison of active and inactive X chromosomal DNA at the CpG island and promoter of human PGK-1. Genes Dev. 4:1277-1287.
43. Qian, X. C., and T. P. Brent. 1997. Methylation hot spots in the 5′ flanking region denote silencing of the O6-methylguanine-DNA methyltransferase gene. Cancer Res. 57:3672-3677.
44. Reed, A. L., J. Califano, P. Cairns, W. H. Westra, R. M. Jones, W. Koch, S. Ahrendt, Y. Eby, D. Sewell, H. Nawroz, J. Bartek, and D. Sidransky. 1996. High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma. Cancer Res. 56:3630-3633.
45. Reznikoff, C. A., T. R. Yeager, C. D. Belair, E. Savelieva, J. A. Puthenveettil, and W. M. Stadler. 1996. Elevated p16 at senescence and loss of p16 at immortalization in human papillomaviras 16 E6, but not E7, transformed human uroepithelial cells. Cancer Res. 56:2886-2890.
46. Riggs, A. D., and G. P. Pfeifer. 1992. X-chromosome inactivation and cell memory. Trends Genet. 8:169-174.
47. Riggs, A. D., Z. Xiong, L. Wang, and J. M. LeBon. 1998. Methylation dynamics, epigenetic fidelity and X chromosome structure. Novartis Found. Symp. 214:214-225.
48. Schutte, M., R. H. Hruban, J. Geradts, R. Maynard, W. Hilgers, S. K. Rabindran, C. A. Moskaluk, S. A. Hahn, I. Schwarte-Waldhof, W. Schmiegel, S. B. Baylin, S. E. Kern, and J. G. Herman. 1997. Abrogation of the Rb/p16 tumor-suppressive pathway in virtually all pancreatic carcinomas. Cancer Res. 57:3126-3130.
49. Serrano, M., G. J. Hannon, and D. Beach. 1993. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 366: 704-707.
50. Sherr, C. J. 1996. Cancer cell cycles. Science 274:1672-1677.
51. Silva, A. J., K. Ward, and R. White. 1993. Mosaic methylation in clonal tissue. Dev. Biol. 156:391-398.
52. Stampfer, M. R. 1985. Isolation and growth of human mammary epithelial cells. J. Tissue Cult. Methods 9:107-115.
53. Stirzaker, C., D. S. Millar, C. L. Paul, P. M. Warnecke, J. Harrison, P. C. Vincent, M. Frommer, and S. J. Clark. 1997. Extensive DNA methylation spanning the Rb promoter in retinoblastoma tumors. Cancer Res. 57:2229-2237.
54. Stoger, R., T. M. Kajimura, W. T. Brown, and C. D. Laird. 1997. Epigenetic variation illustrated by DNA methylation patterns of the fragile-X gene FMR1. Hum. Mol. Genet. 6:1791-1801.
55. Surani, M. A. 1998. Imprinting and the initiation of gene silencing in the germ line. Cell 93:309-312.
56. Toth, M., U. Lichtenberg, and W. Doerfler. 1989. Genomic sequencing reveals a 5-methylcytosine-free domain in active promoters and the spreading of preimposed methylation patterns. Proc. Natl. Acad. Sci. USA 86:3728-3732.
57. Tremblay, K. D., K. L. Duran, and M. S. Bartolomei. 1997. A 5′ 2-kilobase-pair region of the imprinted mouse H19 gene exhibits exclusive paternal methylation throughout development. Mol. Cell. Biol. 17:4322-4329.
58. Vertino, P. M., R.-W. C. Yen, J. Gao, and S. B. Baylin. 1996. De novo methylation of CpG island sequences in human fibroblasts overexpressing DNA (cytosine-5-)-methyltransferase. Mol. Cell. Biol. 16:4555-4565.
59. Watt, F., and P. L. Molloy. 1988. Cytosine methylation prevents binding to DNA of a HeLa cell transcription factor required for optimal expression of the adenovirus major late promoter. Genes Dev. 2:1136-1143.
60. 6-methylguanine DNA methyltransferase (MGMT) CpG island is associated with heterochromatinization of the MGMT transcription start site and silencing of the gene. Mol. Cell. Biol. 17:5612-5619.
61. Wong, D. J., M. T. Barrett, R. Stoger, M. J. Emond, and B. J. Reid. 1997. p16INK4a promoter is hypermethylated at a high frequency in esophageal adenocarcinomas. Cancer Res. 57:2619-2622.
62. Yoder, J. A., N. S. Soman, G. L. Verdine, and T. H. Bestor. 1997. DNA (cytosine-5)-melhyltransferases in mouse cells and tissues. Studies with a mechanism-based probe. J. Mol. Biol. 270:385-395.
63. Zhang, L., X. Cui, K. Schmitt, R. Hubert, W. Navidi, and N. Arnheim. 1992. Whole genome amplification from a single cell: implications for genetic analysis. Proc. Natl. Acad. Sci. USA 89:5847-5851.